.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,221,338

« Back to Dashboard

Details for Patent: 6,221,338

Title: Method of producing particles for use in dry powder inhalers
Abstract:In a method of producing particles suitable for use as carrier particles in dry powder inhalers, particles (1) of a size suitable for use as carrier particles in dry powder inhalers are treated so as to dislodge small grains from the surface of the particles, without substantially changing the size of the particles during the treatment. The treatment gives improved efficiency of redispersion of active particles from the surfaces of carrier particles.
Inventor(s): Staniforth; John Nicholas (Bath, GB)
Assignee: Vectura Limited (London, GB)
Filing Date:May 29, 1996
Application Number:08/633,814
Claims:1. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising the step of milling carrier particles to dislodge asperities from the surfaces of the particles, without substantially changing the size of the particles during the milling, wherein the carrier particles comprise a sugar.

2. A method according to claim 1 wherein at least some of the asperities become reattached to the surfaces of the particles.

3. A method according to claim 1 wherein the milling step is performed in a ball mill.

4. A method according to claim 3 wherein the carrier particles are milled using plastics balls.

5. A method according to claim 3 or 4 wherein the mill is rotated at a speed of less than about 20 revolutions per minute.

6. A method according to claim 3 wherein the mill is rotated at a speed of about six revolutions per minute.

7. A method according to claim 1 wherein the particles are milled for at least one hour.

8. A method according to claim 1 wherein the particles are milled for about six hours.

9. A method according to claim 1 wherein the carrier particles are crystalline sugar particles.

10. A method according to claim 9 wherein the carrier particles are lactose particles.

11. A method according to claim 10 wherein the diameter of the carrier particles lies between 50 .mu.m and 1000 .mu.m.

12. A method according to claim 11 wherein the diameter of the carrier particles lies between 90 .mu.m and 125 .mu.m.

13. A method according to claim 1 wherein the method further includes the step of selecting particles of a size suitable for use as carrier particles prior to the treatment step.

14. A method according to claim 13 wherein the step of selecting particles is a sieving step.

15. A method of producing a dry powder for use in dry powder inhalers, the method including the steps of milling carrier particles according to claim 1, and mixing the milled carrier particles with the active particles of a size suitable for delivery to the lower respiratory tract such that active particles adhere to the surfaces of carrier particles.

16. A method according to claim 15 wherein the carrier particles and the active particles are mixed in a container made from a plastics material.

17. A method according to claim 15 wherein the carrier particles and the active particles are mixed for at least five minutes.

18. A method according to claim 17 wherein the carrier particles and the active particles are mixed for thirty minutes.

19. A method according to claim 17 wherein the mixing is interrupted and the mixture of carrier particles and active particles is sieved.

20. A method according to claim 19 wherein the sieve mesh size is about 250 .mu.m.

21. A method according to claim 15 wherein the carrier particles and active particles are mixed in a ratio by weight of 125 to 1.

22. A method according to claim 15 wherein the diameter of the active particles is between 0.1 .mu.m and 3 .mu.m.

23. A method according to claim 15 wherein the active particles include a .beta..sub.2 -agonist.

24. A method according to claim 23 wherein the active particles include terbutaline, a salt of terbutaline or a combination thereof.

25. A method according to claim 23 wherein the active particles include salbutamol, a salt of salbutamol or a combination thereof.

26. A method according to claim 24 wherein the active particles include salbutamol sulphate.

27. A method of producing a dry powder for use in dry powder inhalers, the method including the steps of milling carrier particles to dislodge asperities from the surfaces of the carrier particles without substantially changing the size of the carrier particles during the milling step, and mixing the milled carrier particles with active particles such that active particles adhere to the surfaces of carrier particles, wherein the carrier particles comprise a sugar.

28. A method according to claim 27, wherein at least some of the asperities become reattached to the surfaces of the carrier particles.

29. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising the step of milling carrier particles to dislodge asperities from the surfaces of the particles and reattaching dislodged asperities to the surfaces of the particles, wherein the carrier particles comprise a sugar.

30. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising:

selecting carrier particles;

milling or sieving the particles to dislodge asperities from the surfaces of the particles without substantially changing the size of the particles; and

recovering the particles for use as carrier particles in dry powder inhalers, wherein the carrier particles comprise a sugar.

31. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising:

selecting carrier particles;

milling or sieving the particles to dislodge asperities from the surfaces of the particles without substantially changing the size of the particles;

reattaching at least some of the dislodged asperities to the surfaces of the particles; and

recovering the particles for use as carrier particles in dry powder inhalers, wherein the carrier particles comprise a sugar.

32. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising:

selecting carrier particles;

milling the particles using a re-circulated low fluid energy mill to dislodge asperities from the surfaces of the particles; and

recovering the particles for use as carrier particles in dry powder inhalers, wherein the carrier particles comprise a sugar.

33. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising:

selecting particles of a size between 50 .mu.m and 1000 .mu.m suitable for use as carrier particles wherein the carrier particles comprise a sugar;

dislodging asperities from the surfaces of the particles without substantially changing the size of the particles;

reattaching at least some of the dislodged asperities to the surface of the particles; and

recovering the particles for use as carrier particles in dry powder inhalers.

34. A method of producing particles suitable for use as carrier particles in dry power inhalers, the method comprising:

selecting carrier particles comprising a sugar;

milling or sieving the particles to dislodge asperities from the surfaces of the particles;

reattaching at least some of the dislodged asperities to the surfaces of the particles;

mixing the carrier particles with active particles; and

adhering active particles to the surfaces of the carrier particles.

35. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising the step of milling carrier particles to dislodge asperities from the surfaces of the particles, without substantially changing the size of the particles during the milling, wherein the carrier particles comprise a pharmacologically inert material.

36. A method of producing particles suitable for use as carrier particles in dry powder inhalers, the method comprising the step of milling carrier particles to dislodge asperities from the surfaces of the particles and reattaching dislodged asperities to the surfaces of the particles, wherein the carrier particles comprise a pharmacologically inert material.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc